Ilaprazole antisecretory drug of each quadruple therapy the Ilaprazole -based quadruple therapy + Esoprazole antisecretory drug of each quadruple therapy Esoprazole-based quadruple therapy

About Ilaprazole antisecretory drug of each quadruple therapy the Ilaprazole -based quadruple therapy + Esoprazole antisecretory drug of each quadruple therapy Esoprazole-based quadruple therapy

Ilaprazole antisecretory drug of each quadruple therapy the Ilaprazole -based quadruple therapy + Esoprazole antisecretory drug of each quadruple therapy Esoprazole-based quadruple therapy is a approved stage product being developed by Sun Pharmaceutical for Helicobacter Pylori Eradication Antibiotic. The current trial status is completed. This product is registered under clinical trial identifier NCT02835560. Target conditions include Helicobacter Pylori Eradication Antibiotic.

Hype Score Breakdown